A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here's what really went down.

In a state that bans abortion, anxiety about rape and getting pregnant drove this teen to start on birth control, though she's not having sex.

This week’s Medical Minute discusses the role a class of drugs already used to treat cancer and fetal hemoglobin may play in warding off painful and sometimes deadly Sickle Cell Disease crises. 

The Taliban has banned Afghan women working for the U.N. or other aid agencies. The repercussions could be devastating for programs in which women play a vital role.

Members of the Mexican cartel are facing several charges involving fentanyl trafficking, weapons and money laundering in New York, Illinois and Washington, D.C.

A key state agency will recommend a slightly higher wage increase for caregivers who work with people with disabilities in Georgia and who would see a $6 hourly rate increase under the proposal. Gov. Brian Kemp and lawmakers will decide whether to move forward with the recommendations and fund them in the state budget.

At the Skoll World Forum this week, South Africa's Reach Digital Health was one of five honorees. They offer health advice via mobile phones to millions, focusing on pregnancy, babies and COVID.

NPR's Andrew Limbong speaks with culture writer Rebecca Fishbein about her article for Bustle on how "therapy speak" may be making us less empathetic.

The chances of developing lingering symptoms after COVID appears to fall sharply from the first to the second time someone gets sick, new research finds. The risk is still significant.

A new study looks at how urinary tract infections can affect DNA. And down the road that could lead to new treatments for the millions who get UTIs.

The start of pregnancy — as well as exactly when that happens — is a hot topic in some state legislatures and U.S. courts. Understanding the nuances of what happens when has never been more important.

The U.S. Environmental Protection Agency has proposed a new set of restrictions on facilities that use ethylene oxide, a carcinogenic chemical used in sterilizing medical devices.

As the debate over mifepristone makes its way to the Supreme Court, the pharmaceutical industry has raised concerns that ruling against the FDA could chill the development of new drugs.

The Biden administration had asked the higher court to stay a decision from a Texas judge while the appeal plays out.

NPR would like to hear from you. With the future of some abortion pills in jeopardy, tell us about your experience using medication to end a pregnancy or treat a miscarriage.